DETERMINATION OF CEFMENOXIME IN HUMAN-BODY FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引：9

作者：

BORNER, K ^{[1
]}

BORNER, E ^{[1
]}

LODE, H ^{[1
]}

PETERS, A ^{[1
]}

机构：

[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,MED KLIN,D-1000 BERLIN 45,FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1983年 / 2卷 / 01期

关键词：

D O I：

10.1007/BF02019917

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：17 / 21

页数：5

共 7 条

[1]

AVERDUNK R, 1970, Z KLIN CHEM KLIN BIO, V8, P263

[2] INTRAMUSCULAR AND INTRAVENOUS PHARMACOKINETICS OF CEFMENOXIME, A NEW BROAD-SPECTRUM CEPHALOSPORIN, IN HEALTHY-SUBJECTS [J].

GRANNEMAN, GR ;

SENNELLO, LT ;

STEINBERG, FJ ;

SONDERS, RC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :141-145

[3]

REEVES RS, 1976, SELECTED TOPICS CLIN, P21

[4]

SACHS L, 1974, ANGEWANDTE STATISTIK

[5] ANTI-MICROBIAL ACTIVITY OF CEFMENOXIME (SCE-1365) [J].

STAMM, JM ;

GIROLAMI, RL ;

SHIPKOWITZ, NL ;

BOWER, RR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (03) :454-460

[6] CEFMENOXIME (SCE-1365), A NOVEL BROAD-SPECTRUM CEPHALOSPORIN - INVITRO AND INVIVO ANTI-BACTERIAL ACTIVITIES [J].

TSUCHIYA, K ;

KONDO, M ;

KIDA, M ;

NAKAO, M ;

IWAHI, T ;

NISHI, T ;

NOJI, Y ;

TAKEUCHI, M ;

NOZAKI, Y .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (01) :56-65

[7]

TSUCHIYA K, 1981, BETALACTAM ANTIBIOTI, P107

← 1 →